Presentation Details:
Objectives:
- Describe contributions to the research field in HIV and COVID-19 by the AIDS Clinical Trials Group.
- Evaluate the evidence behind investigational and newly approved antiretroviral therapy regimens for intermittent dosing and possibility of contributing toward HIV remission.
- Review key studies related to antiretroviral treatment from CROI 2023.
- Understand range of biomedical HIV prevention approaches.
- Recognize limitations of novel agents for HIV pre-exposure prophylaxis.
Presented by:
Rachel Bender Ignacio, MD, MPH
Assistant Professor
Vaccine and Infectious Disease Division, Fred Hutch
Medical Director
COVID-19 Clinical Research Center, Fred Hutch
Assistant Professor,
Department of Medicine, Division of Allergy & Infectious Diseases,
University of Washington
Jehan Budak, MD
Assistant Professor
Department of Medicine, Division of Allergy & Infectious Diseases
Assistant Medical Director, Madison Clinic
Harborview Medical Center
HIV Pathway Director,
UW Internal Medicine Residency
Chase Cannon, MD
Co-Director,
Public Health Seattle King County Sexual Health Clinic
Acting Assistant Professor,
Department of Medicine, Division of Allergy & Infectious Diseases
University of Washington
Presentation Transcript: